NASDAQ:CGTX

Cognition Therapeutics Stock Insider Trading

etoro logo Buy CGTX
*Your capital is at risk
$1.42
+0.0700 (+5.19%)
At Close: Jun 03, 2026

Cognition Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 81.55. In total, the insiders bought 5.21M and sold 470.38K CGTX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
81.55
Buy 5.21M shares
Sell 470.38K shares
68% Buy Activity
Weak Negative Correlation
Sell Signal Low Confidence
Feb 04, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 81.55.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Jun 07, 2024
Buy
Common Stock
A-Award
Khattar Jack A.
Director
Director 8 500
Value: $16.6K
Jun 07, 2024
Buy
Stock Option (right to buy)
A-Award
Khattar Jack A.
Director
Director 8 500
Value: $16.6K
Jun 07, 2024
Buy
Common Stock
A-Award
Richstone Ellen B
Director
Director 8 500
Value: $16.6K
Jun 07, 2024
Buy
Stock Option (right to buy)
A-Award
Richstone Ellen B
Director
Director 8 500
Value: $16.6K
Jun 07, 2024
Buy
Common Stock
A-Award
Monia Brett P
Director
Director 8 500
Value: $16.6K
Jun 07, 2024
Buy
Stock Option (right to buy)
A-Award
Monia Brett P
Director
Director 8 500
Value: $16.6K
Jun 07, 2024
Buy
Stock Option (right to buy)
A-Award
Monia Brett P
Director
Director 8 500
Value: $16.6K
Jun 07, 2024
Buy
Common Stock
A-Award
Monia Brett P
Director
Director 8 500
Value: $16.6K
Jun 07, 2024
Buy
Stock Option (right to buy)
A-Award
Richstone Ellen B
Director
Director 8 500
Value: $16.6K
Jun 07, 2024
Buy
Common Stock
A-Award
Richstone Ellen B
Director
Director 8 500
Value: $16.6K
Jun 07, 2024
Buy
Stock Option (right to buy)
A-Award
Khattar Jack A.
Director
Director 8 500
Value: $16.6K
Jun 07, 2024
Buy
Common Stock
A-Award
Khattar Jack A.
Director
Director 8 500
Value: $16.6K
Jun 07, 2024
Buy
Stock Option (right to buy)
A-Award
Wallace Peggy
Director
Director 8 500
Value: $16.6K
Jun 07, 2024
Buy
Common Stock
A-Award
Wallace Peggy
Director
Director 8 500
Value: $16.6K
Jun 07, 2024
Buy
Stock Option (right to buy)
A-Award
Fletcher Aaron G.l.
Director 8 500
Value: $16.6K
Jun 07, 2024
Buy
Common Stock
A-Award
Fletcher Aaron G.l.
Director 8 500
Value: $16.6K
Jun 07, 2024
Buy
Stock Option (right to buy)
A-Award
Kreis Leslie W.
Director 8 500
Value: $16.6K
Jun 07, 2024
Buy
Common Stock
A-Award
Kreis Leslie W.
Director 8 500
Value: $16.6K
May 01, 2024
Sell
Common Stock
F-InKind
Doyle John Brendan
Chief Financial Officer
C-Suite Officer 8 699
Value: $17.0K
May 01, 2024
Sell
Common Stock
F-InKind
Doyle John Brendan
Chief Financial Officer
C-Suite Officer 8 699
Value: $17.0K
Mar 14, 2024
Buy
Common Stock
P-Purchase
Ricciardi Lisa
CEO & President
CEO / President 5 700
Value: $10K
Mar 14, 2024
Buy
Common Stock
P-Purchase
Ricciardi Lisa
CEO & President
CEO / President 5 700
Value: $10K
Feb 15, 2024
Buy
Common Stock
A-Award
Doyle John Brendan
Chief Financial Officer
C-Suite Officer 20 000
Value: $0
Feb 15, 2024
Buy
Stock Option (Right to Buy)
A-Award
Doyle John Brendan
Chief Financial Officer
C-Suite Officer 20 000
Value: $39.6K
Feb 15, 2024
Buy
Common Stock
A-Award
Caggiano Anthony
Chief Medical Officer
Officer 60 000
Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT COGNITION THERAPEUTICS, INC.
Cognition Therapeutics
Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical trial for the treatment of mild-to-moderate Alzheimer's disease, as well as has completed Phase I clinica...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE